Insights on ADHD diagnosis, treatment, research, and living well with neurodiversity.
ADHD and financial difficulty are closely linked — not because people with ADHD are irresponsible, but because the cognitive demands of managing money directly clash with the executive function impairments that define the condition. Understanding this link is the first step toward building systems that actually work.
ADHD assessment in the United States costs between $1,500 and $3,500 for a full neuropsychological evaluation at a private practice — a price that excludes millions of people who need it. But the uninsured or underinsured have more options than they may realise. Here is a practical guide to getting assessed without paying out of pocket at a specialist's private rate.
Students with ADHD face a structural disadvantage in standard testing conditions: timed exams penalise slow processing speed, noisy halls exploit attentional vulnerabilities, and multi-hour sittings exhaust working memory. Academic accommodations exist specifically to level this playing field — not to give students with ADHD an advantage, but to remove barriers that prevent their knowledge from being accurately measured. Here is how the accommodation process works and what the research says.
Getting an ADHD assessment in the UK looks very different depending on whether you access it through the NHS or privately. Wait times, costs, the role of GPs, and what happens after diagnosis all differ — and understanding the system before you start can prevent months of unnecessary delay or confusion.
The right ADHD assessment tool depends on the person being evaluated — their age, developmental stage, and, increasingly, their gender. What works for a 7-year-old in a classroom bears little resemblance to what is needed for a 45-year-old woman who has spent decades compensating. Here is a breakdown of how assessment approaches differ across these dimensions.
ADHD and bipolar disorder are among the most frequently confused — and most frequently co-occurring — psychiatric diagnoses in adults. The clinical consequences of confusing them are significant: stimulant treatment, first-line for ADHD, can precipitate manic or hypomanic episodes in bipolar disorder. Mood stabiliser treatment, first-line for bipolar, does nothing for ADHD's core attention and executive function deficits. Getting the differential diagnosis right matters enormously.
ADHD diagnosis is a clinical judgement, not a laboratory result — which means it is subject to the same limitations as all clinical judgements. The honest answer to whether ADHD tests can be wrong is: yes, both false positives and false negatives occur, and understanding why helps you advocate for a more accurate assessment.
ADHD paralysis is what happens when the brain gets stuck — when a task needs to happen, you know it needs to happen, and yet you cannot start. Not won't. Cannot. The distinction matters, because ADHD paralysis is a neurological phenomenon, not a choice or a character trait.